Cheng Sun, ANP

NPI: 1437358892
Total Payments
$2,812
2024 Payments
$840.01
Companies
13
Transactions
27

Payment Breakdown by Category

Food & Beverage$2,595 (92.3%)
Education$216.99 (7.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,595 25 92.3%
Education $216.99 2 7.7%

Top Paying Companies

Company Total Records Latest Year
Incyte Corporation $577.06 5 $0 (2022)
Janssen Biotech, Inc. $376.90 3 $0 (2024)
SANOFI-AVENTIS U.S. LLC $246.41 2 $0 (2024)
Pharmacyclics LLC, An AbbVie Company $240.88 2 $0 (2023)
PFIZER INC. $239.96 3 $0 (2023)
AstraZeneca Pharmaceuticals LP $223.57 2 $0 (2024)
Amgen Inc. $215.68 2 $0 (2024)
Astellas Pharma US Inc $204.23 3 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $125.42 1 $0 (2024)
Daiichi Sankyo Inc. $124.99 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $840.01 8 AstraZeneca Pharmaceuticals LP ($223.57)
2023 $562.46 5 PFIZER INC. ($221.75)
2022 $817.89 7 Incyte Corporation ($455.18)
2021 $591.22 7 Janssen Biotech, Inc. ($234.22)

All Payment Transactions

27 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
09/10/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $118.81 General
08/28/2024 Amgen Inc. Blincyto (Biological) Food and Beverage In-kind items and services $104.75 General
Category: Oncology
08/21/2024 Kite Pharma, Inc. Food and Beverage In-kind items and services $97.34 General
08/20/2024 SANOFI-AVENTIS U.S. LLC REZUROCK (Drug) Food and Beverage In-kind items and services $124.58 General
Category: Oncology
08/15/2024 Janssen Biotech, Inc. TALVEY (Biological), TECVAYLI Food and Beverage In-kind items and services $142.68 General
Category: Oncology
06/27/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $125.42 General
Category: Oncology
05/29/2024 Astellas Pharma US Inc Xospata (Drug) Food and Beverage In-kind items and services $21.67 General
Category: Oncology
01/31/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $104.76 General
12/13/2023 Amgen Inc. Kyprolis (Drug) Food and Beverage In-kind items and services $110.93 General
Category: Oncology
10/24/2023 PFIZER INC. Education In-kind items and services $117.00 General
10/24/2023 PFIZER INC. Food and Beverage In-kind items and services $104.75 General
09/19/2023 Pharmacyclics LLC, An AbbVie Company IMBRUVICA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: ONCOLOGY
08/29/2023 Astellas Pharma US Inc Food and Beverage In-kind items and services $104.79 General
11/17/2022 SANOFI-AVENTIS U.S. LLC REZUROCK (Drug) Food and Beverage In-kind items and services $121.83 General
Category: Oncology
11/01/2022 Incyte Corporation Education Cash or cash equivalent $99.99 General
10/18/2022 Daiichi Sankyo Inc. Food and Beverage In-kind items and services $124.99 General
09/20/2022 Incyte Corporation PEMAZYRE (Drug) Food and Beverage Cash or cash equivalent $106.99 General
Category: Hepatology (Liver, Pancreatic, Gall Bladder)
05/24/2022 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $124.13 General
Category: Hematology/Oncology
04/07/2022 Incyte Corporation MONJUVI (Drug) Food and Beverage Cash or cash equivalent $124.07 General
Category: Oncology
03/23/2022 Pharmacyclics LLC, an AbbVie Company IMBRUVICA (Drug) Food and Beverage In-kind items and services $115.89 General
Category: ONCOLOGY
12/14/2021 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $109.80 General
Category: Oncology
10/26/2021 Astellas Pharma US Inc XOSPATA (Drug) Food and Beverage In-kind items and services $77.77 General
Category: ONCOLOGY
10/19/2021 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $124.42 General
Category: Oncology
07/23/2021 JAZZ PHARMACEUTICALS INC. DEFITELIO (Drug) Food and Beverage Cash or cash equivalent $116.25 General
Category: HEMATOLOGY/ONCOLOGY
06/29/2021 Incyte Corporation MONJUVI (Drug) Food and Beverage Cash or cash equivalent $121.88 General
Category: Oncology

About Cheng Sun, ANP

Cheng Sun, ANP is a Nurse Practitioner healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437358892.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cheng Sun, ANP has received a total of $2,812 in payments from pharmaceutical and medical device companies, with $840.01 received in 2024. These payments were reported across 27 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,595).

Practice Information

  • Specialty Nurse Practitioner
  • Location La Jolla, CA
  • Active Since 07/16/2007
  • Last Updated 11/25/2019
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1437358892

Products in Payments

  • IMBRUVICA (Drug) $475.10
  • REZUROCK (Drug) $246.41
  • MONJUVI (Drug) $245.95
  • TALVEY (Biological) $142.68
  • Nubeqa (Drug) $125.42
  • JAKAFI (Drug) $124.13
  • DEFITELIO (Drug) $116.25
  • Kyprolis (Drug) $110.93
  • PEMAZYRE (Drug) $106.99
  • Blincyto (Biological) $104.75
  • XOSPATA (Drug) $77.77
  • GENERAL HEMOSTASIS (Device) $22.89
  • Xospata (Drug) $21.67
  • BESPONSA (Biological) $18.21

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in La Jolla